Table 3

Relationship Between Intratumoral and Peritumoral ZBTB20 and Clinicopathologic Features

Intratumoral ZBTB20

Peritumoral ZBTB20



Variable

High

(n = 42, 41.2%)

Low

(n = 60, 58.8%)

P

High

(n = 42, 41.2%)

Low

(n = 60, 58.8%)

P


Age(years)

0.523

1.0

≤50

19

31

20

30

>50

23

29

22

30

Gender

0.188

0.188

Male

36

45

36

45

Female

6

15

6

15

Tumor size(mm)

0.299

0.550

≤50

10

20

11

19

>50

32

40

31

41

AFP(ng/ml)

≤20

10

16

0.745

11

15

0.892

>20

32

44

31

45

HBsAg

0.302

0.106

Positive

38

50

39

49

Negtive

4

10

3

11

Pathological stage

0.396*

1.0*

I-II

1

5

2

4

III-IV

41

55

40

56

Liver cirrhosis

0.675

0.172

Yes

31

42

27

46

No

11

18

15

14

Tumor encapsulation

0.235

0.446

Complete

12

27

13

26

Uncomplete

10

10

9

11

No

20

23

20

23

Vein invasion

0.016

0.161

Present

13

7

11

9

Absent

29

53

31

51

Tumour multiplicity

0.064

0.589

Solitary

25

46

28

43

Multiple

17

14

14

17

TNM stage

0.07

0.573

I-II

22

5

25

39

III

20

55

17

21

Recurrence

0.003

0.001

Yes

37

37

38

36

No

5

23

4

24

Metastasis

0.000

0.08

Yes

27

16

22

21

No

15

44

20

39


Abbreviations: HBsAg, hepatitis B s antigen.

*Twenty-five percent of all the cells have expected count less than 5; Fisher's exact test.

Wang et al. BMC Cancer 2011 11:271   doi:10.1186/1471-2407-11-271

Open Data